维普中文期刊产品整合服务
17篇 您的检索式:作者名="BAZEOS A"
    题名 作者 年代 出处 被引量
1Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib 显示文摘Marin D Bazeos A Mahon FX 2010J Clin Oncol2010,28,14:1
2Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib 显示文摘Marin D Bazeos A Mahon FX 2010J Clin Oncol2010,28,14:1
3Adherence is the criticalfactor for achieving molecular responses in patients with chronicmyeloid leukemia who achieve complete cytogenetic responses onimatinib 显示文摘Marin D Bazeos A Mahon FX 2010JClin Oncol2010,28,14:1
4Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic respon- ses on imatinib 显示文摘MARIN D BAZEOS A MAHON F X 2010J Clin Oncol2010,28,14:1
5Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetie responses on imatinib 显示文摘Matin D Bazeos A Mahon FX 2010J Clin Oncol2010,28,14:1
6Adherence is the critical factor for achieveing molecular responses in pa- tients with chronic myeloid leukemia who achieve com- plete cytogenetic responses on imatinib 显示文摘Marin D Bazeos A Mahon FX 2010J Clin Oncol2010,28,14:1
7Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib显示文摘Marin D Bazeos A Mahon F X 2010J Clin Oncol2010,28,14:1
8Adllerence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib显示文摘Marin D Bazeos A Mahon FX 2010J Clin Oncol2010,28,14:1
9Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib显示文摘Marin D Bazeos A Mahon FX 2010J Clin Oncol2010,28,14:1
10Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib 显示文摘Marin D Bazeos A Mahon FX 2010J Clin Oncol2010,28,14:1
11Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib显示文摘Marin D Bazeos A Mahon FX 2010J Clin Oncol2010,28,14:1
12Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib显示文摘Marin D Bazeos A Mahon FX 2010J Clin Oncol2010,28,14:1
13Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cYtogenetic responses on imatinib显示文摘Matin D Bazeos A Mahon FX 2010J Clin Oncol2010,28,:1
14Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib显示文摘Marin D Bazeos A Mahon FX 2010J Clin Oncol2010,28,14:1
15Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease?显示文摘Basset C Holton J Bazeos A 2004Dig Dis Sci2004,49,9:1
16Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease?显示文摘Basset C Holton J Bazeos A 2004Dig Dis Sci2004,49,9:1
17Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib显示文摘Matin D Bazeos A Mahon FX 2010J Clin Oncol2010,28,14:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费